
Episode 513: The Emerging Science of Pomegranates and Urolithin A
Sep 4, 2026 - 26:52
Radio and PodcastLive Radio & Podcasts
This week, Dr. Kahn discusses the widespread disappointment following Novartis' announcement that its 8,000-patient HORIZON trial of a lipoprotein(a)-lowering drug failed to meet its primary endpoint. The news came as a...